drugset / Trial / NCT07308041

A Study to Investigate the Effect of Linaprazan Glurate on the Pharmacokinetics of Amoxicillin

NCT07308041

Phase 1 Completed 12 enrolled Cinclus Pharma Holding AB
NaSingle-groupOpen-labelTreatment

Summary

This is an open, single arm, single-center Phase I trial designed to evaluate the effect of seven days repeated oral doses of linaprazan glurate on the pharmacokinetics (PK) of repeated doses of amoxicillin in healthy male and female participants

Timeline

Start
2025-11-11
Primary completion
2025-12-22
Completion
2025-12-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified
Subject Linaprazan glurate Small molecule Oral